Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 33 Projects
Project # Contact PI Funding Organization Fiscal Year
Cognitive decline in early stages of AD after EGCG and a multimodal therapy
18PTC-R-592192 de la Torre, Rafael Alzheimer's Association 2018
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018
Development of new ATF6/DREAM PPI inhibitors for the treatment of cognitive impairment in AD
ARUK-DC2017-3 Jose Naranjo Alzheimer's Research UK 2017
Therapeutic Effect of rApoA-I-Milano in an AD Model
A2017243S Guillamon, Mar BrightFocus Foundation 2017
Sativex in MCI patients at high risk of developing AD
PTC C-16-422407 Ferrer, Isidro Alzheimer's Association 2016
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016
THERAPEUTIC USE OF EPIGENETIC MODULATORS IN ONCOLOGICAL AND NEURODEGENERATIVE DISEASE
EUJPND-CDTI-GENOMICS-1300 GENOMICS, ORYZON Centre for the Development of Industrial Technology 2016
Therapeutic targeting of impaired lysosomal flux in Alzheimer’s disease
EUJPND-CoEN-Multiple PI-897 Multiple PI Centres of Excellence in Neurodegeneration 2016
Investigating the impact of meditation training on mental health and wellbeing in the ageing population
EUJPND-European Commission-EC Grant-1053 EC Grant European Commission 2016
Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies
EUJPND-European Commission-EC Grant-1064 EC Grant European Commission 2016